Volume 7, Issue 7:Title of Issue: Genotype-Phenotype Correlation and Individualizing Therapy
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 7, Issue 7)
Target Audience
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
Learning Objectives
After participating in this activity, the participant will demonstrate the ability to:
- Explain the role of new CFTR-mutation specific therapies.
- Describe how new biomarkers can influence our understanding of disease severity and response to therapies.
- Summarize the concept of theratyping.
Bryan A. Garcia, MD
Fellow Pulmonary and Critical Care Medicine
University of Alabama
Birmingham, Alabam
Fellow Pulmonary and Critical Care Medicine
University of Alabama
Birmingham, Alabam
George M. Solomon, MD
Assistant Professor Division of Pulmonary, Allergy, and Critical Care Medicine
University of Alabama
Birmingham, Alabam
Assistant Professor Division of Pulmonary, Allergy, and Critical Care Medicine
University of Alabama
Birmingham, Alabam
Available Credit
- 1.00 ANCC
- 1.00 Attendance